Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

azenosertibNeutral

AI Analysis

Summary

Zentalis Pharmaceuticals granted non-qualified stock options to purchase 62,000 shares to three newly hired employees under its 2022 Inducement Plan as inducement compensation in accordance with Nasdaq listing rules.

Importance:1/10

Sentiment:

0.00

inducement grantsemployee compensationstock optionsNasdaq Rule 5635(c)(4)

Related Companies

$ZNTL

Read the original article

Published by GlobeNewswire Pharma on October 1, 2026 9:10 PM

Read Original